name,pdb_id,pubmed_id,resolution,uniprot,PFAM,CATH,receptor_chain,receptor_length,peptide_chain,peptide_length,sequence_alignment,stride,percent_exposed_alignment,cluster_number,binding_mode,size_of_binding_mode,core_ecr_alignment,longest_continuous_core,longest_continuous_ecr,corebinding_aa,exosite_aa,surface_aa,interior_aa,corebinding_ss,exosite_ss,surface_ss,interior_ss,unique_id,COREBINDING_aa,COREBINDING_ss,EXOSITE_aa,EXOSITE_ss,bfact,bs_loc_type,full_peptide_sequece,mean_seq_iden_in_bm,mean_seq_iden_not_bm,min_dist_E_C_diff_bm,occupancy,pep_loc_type,title
3MNE_A_B_86_1.pdb,3MNE,20850457,1.96,P06537,PF00104,1.10.565.10,A,253,B,10,E---NAL-LRYLLD-,C---CHH-HHHHHC-,3---021-023003-,86,1,3,e---CCC-CCCCCC-,9,1,E:0;F:0;I:0;K:0;L:0;M:0;N:0;Q:0;V:0,E:0;F:0;I:0;K:0;L:0;M:0;N:0;Q:0;V:0,A:3;C:1;D:2;E:7;G:3;K:7;L:1;M:2;N:2;P:4;Q:4;R:3;S:6;V:1;W:2;Y:1,A:11;C:4;D:7;E:7;F:9;G:7;H:4;I:14;K:7;L:35;M:10;N:7;P:7;Q:10;R:7;S:12;T:12;V:9;W:3;Y:9,G:0;H:0,G:0;H:0,C:19;G:4;H:18;T:8,C:21;E:13;G:1;H:138;T:18,86_1,E:2;F:1;I:1;K:1;L:2;M:2;N:1;Q:2;V:1,G:1;H:12,E:0;F:0;I:0;K:0;L:0;M:0;N:0;Q:0;V:0,G:0;H:0,9---999-999999-,ASN_236_A_COREBINDING;GLN_69_A_COREBINDING;GLN_74_A_COREBINDING;GLU_228_A_COREBINDING;GLU_232_A_COREBINDING;ILE_49_A_COREBINDING;LEU_66_A_COREBINDING;LEU_73_A_COREBINDING;LYS_56_A_COREBINDING;MET_229_A_COREBINDING;MET_70_A_COREBINDING;PHE_61_A_COREBINDING;VAL_52_A_COREBINDING,KENALLRYLLDKD,0.792490118577075,0.474308300395257,2.79282473492341,9---999-999999-,GLU_1_B_e;ASN_2_B_C;ALA_3_B_C;LEU_4_B_C;LEU_5_B_C;ARG_6_B_C;TYR_7_B_C;LEU_8_B_C;LEU_9_B_C;ASP_10_B_C,"CRYSTAL STRUCTURE OF THE AGONIST FORM OF MOUSE GLUCOCORTICOID RECEPTOR 2 STABILIZED BY F608S MUTATION AT 196A"
4LSJ_A_B_86_1.pdb,4LSJ,24446728,2.35,P04150,PF00104,1.10.565.10,A,244,B,10,----SSR-LWELLME,----HHH-HHHHHHC,----121-0220013,86,1,3,----CCC-CCCCCCe,9,1,E:0;F:0;I:0;K:0;L:0;M:0;N:0;Q:0;V:0,E:0;F:0;I:0;K:0;L:0;M:0;N:0;Q:0;V:0,A:3;D:3;E:7;G:1;I:1;K:9;L:3;N:1;P:7;Q:5;R:4;S:5;T:4;V:3;W:1;Y:4,A:8;C:4;D:7;E:6;F:8;G:8;H:5;I:11;K:3;L:32;M:11;N:8;P:3;Q:7;R:5;S:12;T:9;V:8;W:4;Y:9,G:0;H:0,G:0;H:0,C:16;E:1;G:4;H:23;T:17,C:14;E:14;G:1;H:123;T:16,86_1,E:2;F:1;I:2;K:2;L:2;M:2;N:1;Q:2;V:1,G:1;H:14,E:0;F:0;I:0;K:0;L:0;M:0;N:0;Q:0;V:0,G:0;H:0,----976-5666689,ASN_227_A_COREBINDING;GLN_67_A_COREBINDING;GLN_72_A_COREBINDING;GLU_219_A_COREBINDING;GLU_223_A_COREBINDING;ILE_224_A_COREBINDING;ILE_47_A_COREBINDING;LEU_64_A_COREBINDING;LEU_71_A_COREBINDING;LYS_51_A_COREBINDING;LYS_54_A_COREBINDING;MET_220_A_COREBINDING;MET_68_A_COREBINDING;PHE_59_A_COREBINDING;VAL_50_A_COREBINDING,HSSRLWELLMEAT,0.858675649293498,0.459016393442623,5.67553037169215,----999-9999999,SER_1_B_C;SER_2_B_C;ARG_3_B_C;LEU_4_B_C;TRP_5_B_C;GLU_6_B_C;LEU_7_B_C;LEU_8_B_C;MET_9_B_C;GLU_10_B_e,"CRYSTAL STRUCTURE OF THE GLUCOCORTICOID RECEPTOR LIGAND BINDING DOMAIN 2 BOUND TO A DIBENZOXAPINE SULFONAMIDE"
4MDD_A_C_86_1.pdb,4MDD,,2.40,P04150,PF00104,1.10.565.10,A,247,C,13,-LGLE-DIIRKALMG,-HHHH-HHHHHHHHC,-2211-210130034,86,1,3,-eeeC-CCCCCCCCe,9,3,G:0;I:0;K:0;L:0;M:0;N:0;Q:0;V:0;W:0,G:0;I:0;K:1;L:0;M:0;N:1;Q:0;V:0;W:1,A:4;D:4;E:7;F:1;I:2;K:8;L:3;M:1;N:3;P:6;Q:3;R:5;S:7;T:3;V:2;Y:4,A:10;C:4;D:7;E:7;F:8;G:8;H:5;I:11;K:5;L:30;M:11;N:7;P:3;Q:9;R:5;S:13;T:10;V:7;W:3;Y:9,H:0,H:3,C:15;G:2;H:31;T:15,C:16;E:13;G:1;H:125;T:17,86_1,G:1;I:1;K:0;L:2;M:1;N:0;Q:2;V:2;W:0,H:9,G:0;I:0;K:0;L:0;M:0;N:0;Q:0;V:0;W:0,H:0,-7765-554444457,ASN_230_A_exosite;GLN_63_A_COREBINDING;GLN_68_A_COREBINDING;GLY_39_A_COREBINDING;ILE_43_A_COREBINDING;LEU_60_A_COREBINDING;LEU_67_A_COREBINDING;LYS_50_A_exosite;MET_64_A_COREBINDING;TRP_71_A_exosite;VAL_42_A_COREBINDING;VAL_46_A_COREBINDING,NLGLEDIIRKALMGS,0.848794226368597,0.433198380566802,5.18989730148873,-9999-999999999,LEU_1_C_e;GLY_2_C_e;LEU_3_C_e;GLU_4_C_C;ASP_5_C_C;ILE_6_C_C;ILE_7_C_C;ARG_8_C_C;LYS_9_C_C;ALA_10_C_C;LEU_11_C_C;MET_12_C_C;GLY_13_C_e,"CRYSTAL STRUCTURE OF THE GLUCOCORTICOID RECEPTOR BOUND TO A NON 2 STEROIDAL ANTAGONIST REVEALS REPOSITIONING AND PARTIAL DISORDERING OF 3 ACTIVATION FUNCTION HELIX 12"
4OKW_A_B_86_2.pdb,4OKW,25091737,2.00,P10275,PF00104,1.10.565.10,A,239,B,8,DTLFSQHY,CCHHHHHC,41101210,86,2,1,CCCCCCCC,8,0,E:0;F:0;I:0;K:0;M:0;Q:0;V:0,E:0;F:0;I:0;K:0;M:0;Q:0;V:0,A:2;C:1;D:2;E:1;G:2;H:3;I:2;K:6;M:1;N:3;P:3;Q:1;R:3;S:4;V:2;W:1;Y:2,A:12;C:3;D:9;E:9;F:16;G:7;H:5;I:12;K:5;L:29;M:10;N:7;P:8;Q:10;R:9;S:12;T:4;V:14;W:2;Y:5,G:0;H:0,G:0;H:0,C:10;G:3;H:20;T:6,C:21;E:13;G:2;H:137;T:15,86_2,E:2;F:1;I:1;K:1;M:2;Q:2;V:3,G:1;H:11,E:0;F:0;I:0;K:0;M:0;Q:0;V:0,G:0;H:0,97657776,GLN_63_A_COREBINDING;GLN_68_A_COREBINDING;GLU_216_A_COREBINDING;GLU_220_A_COREBINDING;ILE_67_A_COREBINDING;LYS_50_A_COREBINDING;MET_217_A_COREBINDING;MET_64_A_COREBINDING;PHE_55_A_COREBINDING;VAL_43_A_COREBINDING;VAL_46_A_COREBINDING;VAL_60_A_COREBINDING,NTTDTLFSQHYR,-1,0.455507691468227,,99999999,ASP_1_B_C;THR_2_B_C;LEU_3_B_C;PHE_4_B_C;SER_5_B_C;GLN_6_B_C;HIS_7_B_C;TYR_8_B_C,"CRYSTAL STRUCTURE OF W741LARLBD BOUND WITH COREGULATOR PEPTIDE"
